Literature DB >> 33575713

Letter to the Editor: Frailty Phenotype of Homebound Montreal Older Community Dwellers during the COVID-19 Pandemic: Results of a Cross-Sectional Population Study.

C P Launay1, L Cooper-Brown, V Ivensky, O Beauchet.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33575713      PMCID: PMC7768799          DOI: 10.14283/jfa.2020.69

Source DB:  PubMed          Journal:  J Frailty Aging        ISSN: 2260-1341


× No keyword cloud information.
Dear Editor, Recently, Aubertin-Leheurdre & Rolland underscored issues and challenges related to the insufficient physical activity levels observed in the frail older population due to social distancing during the Coronavirus disease 2019 (COVID-19) pandemic (1). Social distancing is an effective intervention to limit the spread of COVID-19 (2). However, for older community dwellers social distancing implies homebound which may lead to a decline in physical activity, increased gait and balance disorders, cardiovascular disease burden and morality risk (1, 3, 4). Frailty refers to a condition of vulnerability to physical and psychological stressors that exposes individuals to incident adverse health events, disabilities and death (5–7). There are two frailty phenotypes: physical and mental (6, 7). We suggested that frailty phenotypes may confer distinct risks for adverse outcomes to homebound older community dwellers. To explore this research hypothesis, there is a need to first gather information about homebound older adults’ physical and mental frailty phenotypes at the onset of confinement. Montreal (Quebec, Canada) is an urban area that is particularly affected by the COVID-19 pandemic, being, as of May 2020, the city with the highest number of confirmed COVID-19 cases in Canada (8). The confinement of Montreal’s older adults will be therefore lasting longer than initially anticipated. A short assessment tool, known as “Évaluation SOcio-GÉRiatrique” (ESOGER), for Montreal’s older community-dwelling population has been designed in March 2020. ESOGER allows to screen both physical and mental frailty. The objective of the present study is to describe the clinical characteristics and frailty phenotype of Montreal’s older community dwellers, assessed with ESOGER after one month of being homebound. Between April 20 and May 08, 2020, 879 older community dwellers were recruited to participate in this cross-sectional study. Selection criteria were: age ≥70 years, being homebound, understanding French and/or English and agreeing to participate in the study. ESOGER is a clinical assessment consisting of a digital questionnaire that includes close-ended questions exploring five complementary subdomains, including: 1) COVID-19 clinical symptomatology (i.e., fever ≥38°C/100F, cough, shortness of breath and other symptoms); 2) a frailty assessment performed using the 6-item brief geriatric assessment (BGA), 3) psychological stress using a verbal analogue scale (VAS) of anxiety ranging from 0 (i.e., no anxiety) to 10 (i.e., severe anxiety) (9). ESOGER can be filled out by health and social professionals, as well as by trained volunteers, through a phone call with older community dwellers or their caregivers. Participants were separated into 4 groups based on their frailty phenotype as per the 6-item BGA: no frailty, physical frailty (i.e., use of a walking aid), mental frailty (i.e., temporal disorientation associated with anxiety), and a combination of physical and mental frailty. Participants’ characteristics were summarized using frequencies and percentages. Between-group comparisons were performed using Chi-squared tests. P-values less than 0.001 were considered statistically significant because of multiple comparisons (n = 42). All statistics were performed using SPSS (version 24.0; SPSS, Inc., Chicago, IL). The study was approved by the Ethics Committee Of thé Jewish General Hospital (Montreal, Quebec, Canada). The overall prevalence of frailty was 65.0%; the most prevalent type was physical frailty 38.3%, whereas the prevalence of mental frailty was 12.5%, and that of both frailties combined was 14.1% (Table 1). Participants identified as physically frail were older, used home support, and experienced polypharmacy at a higher rate than those with no frailty (P≤0.001) and those with mental frailty (P≤0.001). Participants combining both types of frailty took more medications compared to those with no frailty (P≤0.001) and had home support more often than those with mental frailty only (P≤0.001). There were no significant differences between groups for the other characteristics.
Table 1

Characteristics of participants separated into four groups based on their frailty phenotype (n=879)

Total population (n=879)FrailtyP-Value*
No (n=308)Yes (n=571)OverallNo frailty versusPhysical Frailty versusMental Frailty versus both
Physical (n=337)Mental (n=110)Both (n=124)Physical frailtyMental frailtyBothMental frailtyBoth
Age ≥ 85, n (%)454 (51.6)132 (42.9)223 (66.2)34 (30.9)65 (52.4)≤0.001≤0.0010.0050.071≤0.0010.0070.001
Female, n (%)582 (66.2)203 (65.9)224 (66.5)69 (62.7)86 (69.4)0.7610.8810.4100.4910.4730.5580.285
Living alone, n (%)376 (42.8)124 (40.3)160 (47.5)38 (34.5)54 (43.5)0.0750.0650.2030.5300.0180.4530.159
Home support†, n (%)513 (58.4)156 (50.6)233 (69.1)43 (39.1)81 (65.3)≤0.001≤0.0010.0030.006≤0.0010.436≤0.001
Polypharmacy‡, n (%)434 (49.4)116 (37.7)201 (59.6)44 (40.0)73 (58.9)≤0.001≤0.0010.478≤0.001≤0.0010.8810.004
COVID-19 positive§, n (%)5 (0.6)02 (0.6)1 (0.9)2 (1.6)0.0230.1760.5730.0250.7250.2950.653
Use of a walking aid¶, n (%)461 (52.4)337 (100.0)124 (100.0)
Temporal disorientation#, n (%)43 (4.9)25 (22.7)18 (14.5)
Anxiety**, n (%)199 (22.6)88 (80.0)111 (89.5)

*: based on Chi-squared test; †: Formal (i.e., health and/or social professionals) or informal (i.e., family and/or friends); ‡Number of different medications taken daily ≥5; §: Older adults with at least 3 COVID-19 symptoms among fever ≥ 38°C /100°F, cough, shortness of breath and other symptoms; % cane and rolling walker; #: Inability to give the month and/or year; **: Highest tertile of the verbal analogue anxiety scale score ranging from 0 (no anxiety) to 10 (severe anxiety).

Characteristics of participants separated into four groups based on their frailty phenotype (n=879) *: based on Chi-squared test; †: Formal (i.e., health and/or social professionals) or informal (i.e., family and/or friends); ‡Number of different medications taken daily ≥5; §: Older adults with at least 3 COVID-19 symptoms among fever ≥ 38°C /100°F, cough, shortness of breath and other symptoms; % cane and rolling walker; #: Inability to give the month and/or year; **: Highest tertile of the verbal analogue anxiety scale score ranging from 0 (no anxiety) to 10 (severe anxiety). These findings illustrate the high prevalence of frailty, especially of the physical phenotype, among homebound older community dwellers in Montreal. This result provides insight into the importance of prioritising preventive interventions that target insufficient physical activity in times of social distancing. Indeed, it is well known that older community dwellers with physical frailty are at increased risk for motor deconditioning and related adverse outcomes, which include muscle mass decline and increasingly unstable gait and balance, ultimately increasing the risk of falls and fractures (1). In this population, patient-centred care should include offering physical activity programs that take into account physical distancing measures (10). As suggested by Aubertin-Leheurdre & Rolland, innovative gerontechnology solutions such as exergames or web-based exercise programs may address the risk being homebound poses to older community dwellers (1).
  8 in total

1.  Update of the 6-Item Brief Geriatric Assessment Screening Tool of Older Inpatients at Risk for Long Length of Hospital Stay: Results From a Prospective and Observational Cohort Study.

Authors:  Olivier Beauche; Julia Chabot; Shek Fung; Cyrille P Launay
Journal:  J Am Med Dir Assoc       Date:  2018-04-26       Impact factor: 4.669

2.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

3.  Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group.

Authors:  E Kelaiditi; M Cesari; M Canevelli; G Abellan van Kan; P-J Ousset; S Gillette-Guyonnet; P Ritz; F Duveau; M E Soto; V Provencher; F Nourhashemi; A Salvà; P Robert; S Andrieu; Y Rolland; J Touchon; J L Fitten; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

4.  Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation.

Authors:  Harpal S Buttar; Timao Li; Nivedita Ravi
Journal:  Exp Clin Cardiol       Date:  2005

5.  "Social Distancing" Amid a Crisis in Social Isolation and Loneliness.

Authors:  Thomas K M Cudjoe; Ashwin A Kotwal
Journal:  J Am Geriatr Soc       Date:  2020-05-15       Impact factor: 5.562

6.  Frailty in the face of COVID-19.

Authors:  Ruth E Hubbard; Andrea B Maier; Sarah N Hilmer; Vasi Naganathan; Christopher Etherton-Beer; Kenneth Rockwood
Journal:  Age Ageing       Date:  2020-07-01       Impact factor: 10.668

7.  Letter to the Editor: COVID-19 Quarantine in Older People: The Need to Think about Sarcopenia-Related Phenotypes.

Authors:  A Bonadias Gadelha; R M Lima
Journal:  J Frailty Aging       Date:  2020

8.  The Importance of Physical Activity to Care for Frail Older Adults During the COVID-19 Pandemic.

Authors:  Mylene Aubertin-Leheudre; Yves Rolland
Journal:  J Am Med Dir Assoc       Date:  2020-04-30       Impact factor: 4.669

  8 in total
  1 in total

1.  Benefits of a 3-month cycle of weekly virtual museum tours in community dwelling older adults: Results of a randomized controlled trial.

Authors:  Olivier Beauchet; Jacqueline Matskiv; Kevin Galery; Linda Goossens; Constance Lafontaine; Kim Sawchuk
Journal:  Front Med (Lausanne)       Date:  2022-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.